Clinical Efficacy and Safety of Intravenous levofloxacin in Patients of Abdominal Operati / 한국간담췌외과학회지
Korean Journal of Hepato-Biliary-Pancreatic Surgery
; : 169-173, 2001.
Article
in Ko
| WPRIM
| ID: wpr-153648
Responsible library:
WPRO
ABSTRACT
BACKGROUND/AIMS: For the investigation of the efficacy and safety of intravenous levofloxacin, The clinical study was carrried out in 30 patients with abdominal operation, especially in hepatobiliary and pancreatic division. METHODS: Randomly chosen patients received intravenous levofloxacin (250mg bid) for only 7 days. Clinical and microbiological evaluation were conducted on the day of starting and finishing levofloxacin treatmeat except for the case of combined use of antibiotics. RESULTS: The most commonly isolated organism was staphylococcus aureus(33%, 3/9). The overall bacteriologic eradication rate was 67%, (6/9) with clinical success rate was 96%(29/30), There were no significant dverse effects to stop the administration of the drug. CONCLUSION: These results suggest that intravenous levofloxacin is effective and safe antibiotics in the fields management of abdominal operation especially in hepatobiliary and pancreas surgery.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Pancreas
/
Staphylococcus
/
Levofloxacin
/
Anti-Bacterial Agents
Limits:
Humans
Language:
Ko
Journal:
Korean Journal of Hepato-Biliary-Pancreatic Surgery
Year:
2001
Type:
Article